Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohort

BACKGROUND: To determine if testosterone levels are influenced by dopaminergic therapy in Parkinson disease (PD) patients. Testosterone level has been reported to be low in patients with PD and other neurodegenerative diseases. In this study, we sought to determine whether dopaminergic therapy (i.e....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Mov Disord
Asıl Yazarlar: Okun, Michael S, Wu, Samuel S, Jennings, Dana, Marek, Kenneth, Rodriguez, Ramon L, Fernandez, Hubert H
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4711001/
https://ncbi.nlm.nih.gov/pubmed/26788334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2054-7072-1-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller